Centric Wealth Management Abb Vie Inc. Call Options Transaction History

Centric Wealth Management

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Oct 06, 2021	SELL	$106.4 - $120.78 $95,760 - $108,702	-900 Reduced 28.13%	2,300 $13,000
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $204,600 - $225,240	2,000 Added 166.67%	3,200 $19,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $96,588 - $130,404	1,200 New	1,200 $5,000

3,852

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Centric Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Centric Wealth Management with notifications on news.